We are live on ! Find out more
MBIO icon

Mustang Bio

28 hedge funds and large institutions have $373K invested in Mustang Bio in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

4% more funds holding

Funds holding: 2728 (+1)

0.1% less ownership

Funds ownership: 0.16%0.05% (-0.1%)

52% less capital invested

Capital invested by funds: $774K → $373K (-$401K)

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
6
Reduced
5
Closed
8
Calls
Puts
Net Calls
Net Calls Change

MBIO Hedge Fund Activity: Q2 2024 in Review

28 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2024, worth a combined $373K — down 52% from $774K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MBIO positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.

The largest buyer was UBS Group, adding an estimated $73.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $218K sold.

  • 28 institutional investors held Mustang Bio (MBIO) as of Q2 2024, up from 27 in Q1 2024.
  • Funds reported $373K of Mustang Bio stock for Q2 2024, down 52% quarter-over-quarter.
  • 9 funds opened new Mustang Bio positions in Q2 2024 and 8 closed out, a net change of +1 holder.
  • The largest Mustang Bio buyer in Q2 2024 was UBS Group, an estimated $73.6K added.
  • The largest Mustang Bio seller in Q2 2024 was Armistice Capital, an estimated $218K sold.

Based on aggregated 13F filings for Q2 2024.